Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 73, pseudogene (RN7SL73P)

Target
RN7SL73P
Molecular classification
Other (Pseudogene; non-coding RNA pseudogene)
01

Overview

RN7SL73P stands for “RNA, 7SL, cytoplasmic 73, pseudogene.” This locus is a pseudogene predicted to be similar to the functional 7SL RNA, also called signal recognition particle RNA, but it does not produce a functional protein or participate in canonical biological pathways[1][6]. The 7SL RNA is an important part of the signal recognition particle complex essential for protein targeting, but RN7SL73P itself is a non-functional, non-coding RNA—it is not considered a therapeutic target, receptor, enzyme, or any molecule classically actionable in drug discovery[1][6][7]. There is no evidence that RN7SL73P has a direct role in normal physiology or disease; it does not have documented interactions with drugs, nor does it serve as a biomarker or have known safety/therapeutic implications. Summary of key points: - RN7SL73P is a pseudogene, not a protein-coding gene and not a functional ncRNA[1][6]. - It is not considered a therapeutic target or druggable entity, and there is nothing to suggest it has biological or disease relevance[1][6]. - The entry is technically correct as a locus, but its inclusion as a drug target is incorrect given its biological inactivity[1][6]. - It has no recognized aliases apart from its official nomenclature. - It is not involved in any classified molecular function (such as receptor or enzyme) or in canonical cell signaling/disease pathways. Therefore, RN7SL73P should be classified as a non-functional pseudogene and not as a drug or therapeutic target.

Other names
RN7SL73P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 73, pseudogene (RN7SL73P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 73, pseudogene (RN7SL73P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call